These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24889923)

  • 41. Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation.
    Yanagimachi M; Naruto T; Tanoshima R; Kato H; Yokosuka T; Kajiwara R; Fujii H; Tanaka F; Goto H; Yagihashi T; Kosaki K; Yokota S
    Clin Transplant; 2010; 24(6):855-61. PubMed ID: 20030680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do drug transporter (ABCB1) SNPs influence cyclosporine and tacrolimus dose requirements and renal allograft outcome in the posttransplantation period?
    Singh R; Srivastava A; Kapoor R; Mittal RD
    J Clin Pharmacol; 2011 Apr; 51(4):603-15. PubMed ID: 20571034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of ABCB1 genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis.
    Wu H; Kang H; Liu Y; Xiao Q; Zhang Y; Sun M; Liu D; Wang Z; Zhao H; Yao W; Jia T; Wang E; Zheng Z; Wei M
    Pharmacogenomics; 2013 Jun; 14(8):897-911. PubMed ID: 23746184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CARD15/NOD2 single nucleotide polymorphisms do not confer susceptibility to type I psoriasis.
    Plant D; Lear J; Marsland A; Worthington J; Griffiths CE
    Br J Dermatol; 2004 Sep; 151(3):675-8. PubMed ID: 15377357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclosporine: a new therapeutic option for severe, recalcitrant psoriasis.
    Gilleaudeau P; McClelland PB
    Dermatol Nurs; 1994 Dec; 6(6):395-405; quiz 406-7. PubMed ID: 7727196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling.
    Oestreicher JL; Walters IB; Kikuchi T; Gilleaudeau P; Surette J; Schwertschlag U; Dorner AJ; Krueger JG; Trepicchio WL
    Pharmacogenomics J; 2001; 1(4):272-87. PubMed ID: 11911124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Failure of cyclosporine in the treatment of psoriasis: role of lithium?].
    Castanet J; Lacour JP; Van Eslande L; Belgodere X; Ortonne JP
    Presse Med; 1995 Jan; 24(1):41. PubMed ID: 7899339
    [No Abstract]   [Full Text] [Related]  

  • 48. Topical cyclosporine is ineffective in the treatment of psoriasis.
    Delfino M; Brunetti B; Fabbrocini G
    Int J Dermatol; 1992 Dec; 31(12):895. PubMed ID: 1478774
    [No Abstract]   [Full Text] [Related]  

  • 49. Cyclosporine and angiogenesis in psoriasis.
    Li VW; Li WW
    J Am Acad Dermatol; 1996 Dec; 35(6):1019-21. PubMed ID: 8959979
    [No Abstract]   [Full Text] [Related]  

  • 50. [Symposium report: "Therapy of severe psoriasis with Sandimmune". Symposium of Nurnberg Sandoz AG 13 February 1993, Nurnberg].
    Sticherling M
    Hautarzt; 1994 Jan; 45(1):50-2. PubMed ID: 8150621
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacogenetics and psoriasis: is targeted treatment a possibility?
    Vasilopoulos Y
    Pharmacogenomics; 2017 Dec; 18(18):1627-1630. PubMed ID: 29173005
    [No Abstract]   [Full Text] [Related]  

  • 52. Psoriasis and cigarettes. Another nail in the coffin.
    Baughman RD
    Arch Dermatol; 1993 Oct; 129(10):1329-30. PubMed ID: 8215501
    [No Abstract]   [Full Text] [Related]  

  • 53. A pharmacogenetic study of psoriasis supports the association between a gene (KLK7) and treatment response.
    Br J Dermatol; 2023 Dec; 190(1):e8. PubMed ID: 38124525
    [No Abstract]   [Full Text] [Related]  

  • 54. Combination therapy of cyclosporine and anti-tumor necrosis factor α in psoriasis: a case series of 10 patients.
    Cohen Barak E; Kerner M; Rozenman D; Ziv M
    Dermatol Ther; 2015; 28(3):126-30. PubMed ID: 25640261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of genetic polymorphisms on the efficacy and side effects of anastrozole in postmenopausal breast cancer patients.
    Abubakar MB; Wei K; Gan SH
    Pharmacogenet Genomics; 2014 Dec; 24(12):575-81. PubMed ID: 25203739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retrospective pharmacogenetic study of psoriasis highlights the role of KLK7 in tumour necrosis factor signalling.
    Zhang H; Patrick MT; Tejasvi T; Sarkar MK; Wasikowski R; Stuart PE; Li Q; Xing X; Voorhees JJ; Ward NL; He K; Zhou X; Gudjonsson JE; Nair RP; Elder JT; Tsoi LC
    Br J Dermatol; 2023 Dec; 190(1):70-79. PubMed ID: 37672660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic Influence on Treatment Response in Psoriasis: New Insights into Personalized Medicine.
    Berna-Rico E; Perez-Bootello J; Abbad-Jaime de Aragon C; Gonzalez-Cantero A
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacogenomics on the Treatment Response in Patients with Psoriasis: An Updated Review.
    Wang CY; Wang CW; Chen CB; Chen WT; Chang YC; Hui RC; Chung WH
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine.
    Antonatos C; Asmenoudi P; Panoutsopoulou M; Vasilopoulos Y
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacogenetic Study of the Impact of
    Chernov A; Kilina D; Smirnova T; Galimova E
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.